Jeffrey Golden, MD

Associate medical director of the Lung Transplantation Program

Dr. Jeffrey Golden, associate medical director of Lung Transplantation, is a pulmonologist who treats patients with severe lung disease, particularly candidates for lung transplants. In addition, he is director of clinical trials for the Interstitial Lung Disease Program. In 2010, one of Golden's longtime patients, Nina Ireland, left $48 million — almost her entire estate — to UCSF to create the Nina Ireland Lung Disease Program.

Golden earned a bachelor's degree at Yale University and a medical degree at Washington University in St. Louis in 1972. He completed internal medicine and pulmonary training at UCSF. He completed pulmonary research training at UCSF's Cardiovascular Research Institute where he studied ozone inhalation in humans as a model of asthma. He is a professor of clinical medicine at UCSF.

Clinics

ILD Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-2577
Fax: (415) 353-8944

Lung Transplant Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday 8 a.m. – 5 p.m. (exact times vary depending on number of physicians in clinic)

Pulmonary Practice at Parnassus
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0359
Phone: (415) 353-2961
Fax: (415) 353-2568

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

Academic Title

Professor

More about Jeffrey Golden

Education

Washington University School of Medicine 1972

Residencies

UCSF Medical Center, Internal Medicine 1975

Fellowships

UCSF Medical Center, Pulmonary Medicine 1977

Selected Research and Publications

  1. Raghu G, van den Blink B, Hamblin MJ, Brown AW, Golden JA, Ho LA, Wijsenbeek MS, Vasakova M, Pesci A, Antin-Ozerkis DE, Meyer KC, Kreuter M, Santin-Janin H, Mulder GJ, Bartholmai B, Gupta R, Richeldi L. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial. JAMA. 2018 May 20.
  2. Singer JP, Soong A, Bruun A, Bracha A, Chin G, Hays SR, Kukreja J, Rigler J, Golden JA, Greenland JR, Garvey C. A mobile health technology enabled home-based intervention to treat frailty in adult lung transplant candidates: A pilot study. Clin Transplant. 2018 May 09; e13274.
  3. Hachem RR, Kamoun M, Budev MM, Askar M, Ahya VN, Lee JC, Levine DJ, Pollack MS, Dhillon GS, Weill D, Schechtman KB, Leard LE, Golden JA, Baxter-Lowe L, Mohanakumar T, Tyan DB, Yusen RD. Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study. Am J Transplant. 2018 Apr 24.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.